Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
Thomas R.M. Bieber, Kristian Reich, Carle F. Paul, Yuichiro Tsunemi, Matthias Augustin, J.‐P. Lacour and 10 more
- Rank
- 11 of 725
- Percentile
- top 1.6%
- Where
- British Journal of Dermatology, 2022
- Citations
- 80
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.